Loading News...
Back to Dashboard

Hims & Hers Health, Inc. (HIMS)

Real-time intraday values

Market Overview

From:
To:
HIMS Intraday
No data available
SymbolHIMS
IPO DateSep 13, 2019
CEOMr. Andrew Dudum
Full Time Employees2.4k
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
ExchangeNYSE
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.
Performance
PeriodReturn %Value Change
1 Day
+3.88%
+1.17 US$
5 Days
+8.56%
+2.47 US$
1 Month
+25.11%
+6.29 US$
6 Months
-10.38%
-3.63 US$

Analyzing Market with AI

Evaluating the last 30 days of history and fundamental metrics of HIMS...

Key Statistics
Market Cap
7.25B
P/E Ratio
N/A
Div Yield
N/A
52W High
$70.43
52W Low
$13.74

Analyst Consensus

ConsensusHold
Bullish425.0%
Neutral1275.0%
Bearish00.0%

52W Analyst Price Targets

Min Target
$21.00
Max Target
$35.00
Current$31.34
Avg Target$26.61

Analyst Recommendations

Target Price:$26.61($21.00 - $35.00)
FirmRatingTarget PriceUpside PotentialDate
B of A SecuritiesNeutral$25.00-20.23%5/26/2026
Truist SecuritiesHold$23.00-26.61%5/22/2026
B of A SecuritiesNeutral$28.00-10.66%5/19/2026
B of A SecuritiesNeutral$30.00-4.28%5/13/2026
CitigroupNeutral$28.00-10.66%5/12/2026
JP MorganOverweight$33.00+5.30%5/12/2026
BTIGNeutral$0.00-100.00%5/12/2026
NeedhamBuy$35.00+11.68%5/12/2026
JP MorganOverweight$35.00+11.68%4/24/2026
B of A SecuritiesNeutral$32.00+2.11%4/24/2026
Community Thoughts

Share your analysis and sentiment on HIMS

Join the community to share your analysis